Literature DB >> 31759086

Expression and purification of recombinant mouse CRISP4 using a baculovirus system.

Avinash S Gaikwad1, Khai Lee Loh2, Anne E O'Connor1, Hugh H Reid3, Moira K O'Bryan4.   

Abstract

Cysteine-rich secretory protein 4 (CRISP4) is a member of the CAP superfamily protein, is highly expressed in the male reproductive tract and is required for optimal mammalian fertility. CRISPs are characterized by the presence of 16 conserved cysteine residues which forms 8 disulphide bond spread across the N-terminal CAP domain, a hinge region and a C-terminal ion channel regulatory (ICR) domain. Previous attempts to purify recombinant CRISPs as a group have resulted in misfolded and/or insoluble recombinant proteins, protein aggregates or unusable low protein yield. Thus, defining the functions of CRISPs have been impeded. In this study, we report a three-step purification protocol for expression and purification of mouse CRISP4 protein in High Five™ cells using a baculovirus expression system. Recombinant mouse CRISP4 was recognized by western blotting and structurally characterized using Circular Dichroism (CD). Using the protocol described herein, we generated high yields of soluble and correctly folded recombinant mouse CRISP4.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAP proteins; CRISP4; Cysteine-rich secretory protein; Epididymal CRISP; Insect cell expression

Year:  2019        PMID: 31759086     DOI: 10.1016/j.pep.2019.105543

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Recombinant Protein Production and Purification of Insoluble Proteins.

Authors:  Neus Ferrer-Miralles; Paolo Saccardo; José Luis Corchero; Elena Garcia-Fruitós
Journal:  Methods Mol Biol       Date:  2022

2.  The Sertoli cell expressed gene secernin-1 (Scrn1) is dispensable for male fertility in the mouse.

Authors:  Brendan J Houston; Liina Nagirnaja; D Jo Merriner; Anne E O'Connor; Hidenobu Okuda; Kenan Omurtag; Craig Smith; Kenneth I Aston; Donald F Conrad; Moira K O'Bryan
Journal:  Dev Dyn       Date:  2021-01-25       Impact factor: 3.780

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.